Jan 21, 2025, 15:31
César Serrano García: mTOR and PI3K inhibitors can be an effective treatment in GIST SDH-deficient
César Serrano García, Group Leader of VHIO´s Sarcoma Translational Research Group, shared a post on X:
“mTOR and/or PI3K inhibitors can be an effective treatment in GIST SDH-deficient
Activating mutations in the PI3K/mTOR pathway in relapsed/mts samples
Sustained 55-months response with everolimus
We provide other insights on tumor evolution.”
Authors: Carlo María Cicala et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 21, 2025, 15:31
Jan 21, 2025, 15:31
Jan 21, 2025, 15:31
Jan 21, 2025, 15:31
Jan 21, 2025, 15:31
Jan 21, 2025, 15:31